| Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ... Gut 62 (6), 812-823, 2013 | 841 | 2013 |
| Guidelines for the clinical management of familial adenomatous polyposis (FAP) HFA Vasen, G Moeslein, A Alonso, S Aretz, I Bernstein, L Bertario, ... Gut 57 (5), 704-713, 2008 | 831 | 2008 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 757 | 2012 |
| Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) HFA Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, ... Journal of medical genetics 44 (6), 353-362, 2007 | 752 | 2007 |
| Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ... Jama 307 (4), 382-389, 2012 | 731 | 2012 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 547 | 2015 |
| Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018 | 540 | 2018 |
| Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017 | 539 | 2017 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 493 | 2020 |
| Posttraumatic growth in cancer: reality or illusion? EC Sumalla, C Ochoa, I Blanco Clinical psychology review 29 (1), 24-33, 2009 | 459 | 2009 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 435 | 2021 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| Estimated numbers and prevalence of PI* S and PI* Z alleles of α1-antitrypsin deficiency in European countries I Blanco, FJ De Serres, E Fernandez-Bustillo, B Lara, M Miravitlles European Respiratory Journal 27 (1), 77-84, 2006 | 334 | 2006 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 328 | 2013 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 306 | 2015 |
| Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer V Moreno, F Gemignani, S Landi, L Gioia-Patricola, A Chabrier, I Blanco, ... Clinical Cancer Research 12 (7), 2101-2108, 2006 | 298 | 2006 |
| Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ... European urology 66 (3), 489-499, 2014 | 290 | 2014 |
| POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance F Bellido, M Pineda, G Aiza, R Valdés-Mas, M Navarro, DA Puente, ... Genetics in Medicine 18 (4), 325-332, 2016 | 266 | 2016 |
